Profil
Kala Subramanian ist Senior Vice President-Development & Operations bei der CRISPR Therapeutics AG. In der Vergangenheit war Dr. Subramanian VP & Global Head-Strategic Development bei Novartis Pharmaceuticals Corp. und Senior Project Manager bei Takeda Oncology Co. Sie promovierte an der Cornell University und erwarb einen Abschluss am Indian Institute of Technology Madras.
Aktive Positionen von Kala Subramanian
| Unternehmen | Position | Beginn |
|---|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01.09.2021 |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Corporate Officer/Principal | 01.05.2019 |
Abiologicsb LLC
Abiologicsb LLC BiotechnologyHealth Technology Operates as a biotech company that develops programmable biologic medicines using AI and advanced chemical synthesis | Gründer | 01.01.2021 |
Ehemalige bekannte Positionen von Kala Subramanian
| Unternehmen | Position | Ende |
|---|---|---|
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Gründer | 15.07.2026 |
| CRISPR THERAPEUTICS AG | Geschäftsführer | 01.04.2018 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01.06.2016 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.12.2003 |
Ausbildung von Kala Subramanian
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology Madras
Indian Institute of Technology Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Health Technology |
Abiologicsb LLC
Abiologicsb LLC BiotechnologyHealth Technology Operates as a biotech company that develops programmable biologic medicines using AI and advanced chemical synthesis | Health Technology |
















